CORC

在结果中检索

CORC

浏览/检索结果: 共228条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：23/0  |  提交时间：2023/01/23
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：49/0  |  提交时间：2022/12/30
COG: COnsistent data auGmentation for object perception 会议论文
日本京都（在线）, 2020-11
作者:  
收藏  |  浏览/下载：20/0  |  提交时间：2021/06/28
Mode Transition Control of Dual Tilt Rotor Unmanned Aerial Vehicle Based on Dynamic Analysis 会议论文
Hefei, China, August 22-24, 2020
作者:  Zheng RJ(郑锐剑);  He YQ(何玉庆);  Liu Z(刘重);  Yang LY(杨丽英);  Gu F(谷丰)
收藏  |  浏览/下载：24/0  |  提交时间：2020/10/10
Controller Design and Flight Experiments for the Dual Tilt Rotor Unmanned Aerial Vehicle in Helicopter Mode 会议论文
Athens, GREECE, SEP 01-04, 2020
作者:  Zheng RJ(郑锐剑);  Gu F(谷丰);  Liu Z(刘重);  Zhou H(周浩;  He YQ(何玉庆)
收藏  |  浏览/下载：12/0  |  提交时间：2021/02/27
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Copper-catalyzed asymmetric silylative cyclization of cyclohexadienone-containing 1,6-enynes 会议论文
作者:  Lin, Guo-Qiang;  Tian, Ping;  He, Cheng-Yu;  Xie, Li -Bo;  Ding, Rui
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Design and test of a flexure mount for lightweight mirror 会议论文
Chengdu, China, 2018-06-26
作者:  Ren, Guo-Rui;  Li, Chuang;  Pang, Zhi-Hai;  Chu, Chang-Bo;  Zhang, Hao-Su
收藏  |  浏览/下载：60/0  |  提交时间：2019/03/22
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace